VRTX Vertex Pharmaceuticals Inc

$402.90

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

Website: https://www.vrtx.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
875320
Address
50 NORTHERN AVENUE, BOSTON, MA, US
Valuation
Market Cap
$125.74B
P/E Ratio
nan
PEG Ratio
1.34
Price to Book
7.66
Performance
EPS
$-2.10
Dividend Yield
—
Profit Margin
-4.86%
ROE
-3.15%
Technicals
50D MA
$486.22
200D MA
$470.93
52W High
$519.88
52W Low
$377.85
Fundamentals
Shares Outstanding
257M
Target Price
$498.43
Beta
0.51

VRTX EPS Estimates vs Actual

● Estimated
● Actual

VRTX News & Sentiment

Oct 06, 2025 • Benzinga SOMEWHAT-BULLISH
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years - Vertex Pharmaceuticals ( NASDAQ:VRTX )
Vertex Pharmaceuticals ( NASDAQ:VRTX ) has outperformed the market over the past 20 years by 6.5% on an annualized basis producing an average annual return of 15.61%. Currently, Vertex Pharmaceuticals has a market capitalization of $103.51 billion.
Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Oct 05, 2025 • Motley Fool SOMEWHAT-BULLISH
2 Beaten-Down Stocks Primed for a Comeback
The market is sleeping on these stocks, but you don't have to.
Oct 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Vertex Pharmaceuticals ( VRTX ) Stock Dips While Market Gains: Key Facts
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading day.
Oct 03, 2025 • Benzinga BULLISH
ServiceNow, Vertex Pharmaceuticals And More: CNBC's 'Final Trades' - iShares Core S&P Small-Cap ETF ( ARCA:IJR ) , ServiceNow ( NYSE:NOW )
On CNBC's "Halftime Report Final Trades," on Thursday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he likes ServiceNow, Inc. ( NYSE:NOW ) , which is down 14% year-to-date.
Oct 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Sentiment Snapshot

Average Sentiment Score:

0.253
50 articles with scored sentiment

Overall Sentiment:

Bullish

VRTX Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 03, 2025
Dec 31, 2024 (Pre market)
-0.04 Surprise
  • Reported EPS: $3.98
  • Estimate: $4.02
  • Whisper: —
  • Surprise %: -1.0%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.24 Surprise
  • Reported EPS: $4.38
  • Estimate: $4.14
  • Whisper: —
  • Surprise %: 5.8%
Aug 01, 2024
Jun 30, 2024 (Post market)
-15.77 Surprise
  • Reported EPS: $-12.83
  • Estimate: $2.94
  • Whisper: —
  • Surprise %: -536.4%
May 06, 2024
Mar 31, 2024 (Post market)
0.7 Surprise
  • Reported EPS: $4.76
  • Estimate: $4.06
  • Whisper: —
  • Surprise %: 17.2%
Feb 05, 2024
Dec 31, 2023 (Post market)
0.1 Surprise
  • Reported EPS: $4.20
  • Estimate: $4.10
  • Whisper: —
  • Surprise %: 2.4%
Nov 06, 2023
Sep 30, 2023 (Post market)
0.11 Surprise
  • Reported EPS: $4.08
  • Estimate: $3.97
  • Whisper: —
  • Surprise %: 2.8%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $3.89
  • Estimate: $3.88
  • Whisper: —
  • Surprise %: 0.3%
May 01, 2023
Mar 31, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $3.05
  • Estimate: $3.00
  • Whisper: —
  • Surprise %: 1.7%

Financials